Share Price and Basic Stock Data
Last Updated: October 26, 2025, 11:35 am
| PEG Ratio | 0.72 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Fluidomat Ltd operates in the engineering sector, specializing in the production of fluid management systems. The company’s recent sales performance reflects a strong upward trend, with reported sales of ₹45 Cr in March 2023, increasing to ₹55 Cr in March 2024. The trailing twelve months (TTM) sales stood at ₹69 Cr, highlighting a robust growth trajectory. Quarterly sales data indicates a consistent pattern, with Q1 FY 2025 recording ₹15.65 Cr and Q2 FY 2025 expected to maintain this momentum at ₹15.59 Cr. The company has effectively managed its expenses, which rose from ₹33 Cr in FY 2022 to ₹43 Cr in FY 2025. Notably, the operating profit margin (OPM) has shown significant improvement, reaching 39% in FY 2025, illustrating the company’s operational efficiency and ability to convert sales into profit. This growth in sales and controlled expenses positions Fluidomat favorably within the engineering sector, where average OPMs typically range between 10% to 25%.
Profitability and Efficiency Metrics
Fluidomat’s profitability metrics are strong, underscored by a return on equity (ROE) of 31.4% and return on capital employed (ROCE) of 42.2%. These figures significantly outperform industry averages, indicating effective capital utilization and shareholder value generation. The net profit for FY 2025 reached ₹22 Cr, with earnings per share (EPS) climbing to ₹45.10, up from ₹19.53 in FY 2023. The company’s interest coverage ratio is exceptionally high at 136,101x, reflecting no debt and an ability to cover any interest obligations comfortably. The cash conversion cycle (CCC) stands at 147 days, which, while slightly elevated, remains manageable compared to industry norms. Furthermore, the operating profit has consistently been robust, with an OPM of 39% in FY 2025. These profitability indicators suggest that Fluidomat is not only maintaining healthy margins but is also effectively leveraging its resources to maximize returns.
Balance Sheet Strength and Financial Ratios
Fluidomat’s balance sheet demonstrates remarkable strength, characterized by zero borrowings and total reserves of ₹76 Cr. The absence of debt underscores the company’s conservative financial management, allowing it to retain all earnings for growth and expansion. The current ratio stands at 2.74, indicating strong liquidity and the ability to cover short-term liabilities, which is well above the typical benchmark of 1.5 for healthy companies. The price-to-book value (P/BV) ratio is recorded at 2.10x, suggesting that the market values the company at a premium compared to its book value, a positive indicator for investor confidence. Additionally, the company’s total assets have shown a steady increase from ₹51 Cr in FY 2022 to ₹93 Cr in FY 2025, reflecting growth in both operational capacity and asset base. This financial solidity positions Fluidomat favorably against competitors in the engineering sector, which often grapple with higher leverage ratios.
Shareholding Pattern and Investor Confidence
Fluidomat’s shareholding structure reveals a stable distribution of ownership, with promoters holding 53.45% of the shares, reflecting strong insider confidence in the company’s future. Foreign institutional investors (FIIs) hold a modest 0.58%, indicating limited international interest, while the public holds 45.97% of the shares. The number of shareholders has risen to 8,274, suggesting increasing retail investor participation and confidence in the company’s performance. This growth in the shareholder base is a positive sign, as it indicates broader market interest and potential for future capital inflows. The dividend payout ratio has remained conservative, recorded at 17% for FY 2025, allowing for a significant retention of earnings to fund expansion and operational improvements. This careful approach to dividends, combined with a solid shareholding structure, enhances investor confidence and positions Fluidomat as a stable investment within the engineering sector.
Outlook, Risks, and Final Insight
Fluidomat’s future prospects appear promising, contingent upon several factors. If margins continue to sustain at current levels, the company could see further growth in net profit and cash flows. The absence of debt and a high interest coverage ratio provide a buffer against economic downturns, allowing for strategic investments in innovation and capacity expansion. However, risks remain, including potential fluctuations in raw material costs and supply chain disruptions, which could impact profitability. Additionally, increased competition within the engineering sector may pressure margins. The company’s ability to adapt to market changes and maintain operational efficiency will be critical. With a strong balance sheet and a solid operational framework, Fluidomat is well-positioned to navigate these challenges while capitalizing on growth opportunities in the engineering sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Fluidomat Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| KPT Industries Ltd | 240 Cr. | 706 | 1,266/541 | 18.6 | 201 | 0.42 % | 25.5 % | 22.5 % | 5.00 |
| Miven Machine Tools Ltd | 25.8 Cr. | 85.8 | 112/58.9 | 19.4 | 0.00 % | % | % | 10.0 | |
| Incon Engineers Ltd | 6.15 Cr. | 14.2 | 18.4/9.31 | 0.83 | 0.00 % | 64.2 % | % | 10.0 | |
| Hittco Tools Ltd | 8.87 Cr. | 14.4 | 16.0/10.3 | 5.07 | 0.00 % | 3.21 % | 0.29 % | 10.0 | |
| Harshil Agrotech Ltd | 58.8 Cr. | 0.63 | 14.7/0.48 | 3.67 | 1.23 | 0.00 % | 17.4 % | 16.4 % | 1.00 |
| Industry Average | 3,698.73 Cr | 484.87 | 49.13 | 117.67 | 0.26% | 37.44% | 16.87% | 6.04 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8.91 | 13.03 | 9.92 | 14.29 | 12.56 | 14.65 | 12.63 | 15.65 | 15.59 | 19.00 | 16.64 | 20.95 | 12.39 |
| Expenses | 6.99 | 9.15 | 7.83 | 9.84 | 9.19 | 10.44 | 9.53 | 11.45 | 10.39 | 11.32 | 10.64 | 12.55 | 9.31 |
| Operating Profit | 1.92 | 3.88 | 2.09 | 4.45 | 3.37 | 4.21 | 3.10 | 4.20 | 5.20 | 7.68 | 6.00 | 8.40 | 3.08 |
| OPM % | 21.55% | 29.78% | 21.07% | 31.14% | 26.83% | 28.74% | 24.54% | 26.84% | 33.35% | 40.42% | 36.06% | 40.10% | 24.86% |
| Other Income | 0.35 | 0.39 | 0.36 | 0.17 | 0.59 | 0.70 | 0.58 | 1.58 | 0.67 | 0.76 | 1.33 | 0.70 | 0.79 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.20 | 0.20 | 0.20 | 0.14 | 0.19 | 0.19 | 0.18 | 0.20 | 0.21 | 0.23 | 0.23 | 0.27 | 0.29 |
| Profit before tax | 2.07 | 4.07 | 2.25 | 4.48 | 3.77 | 4.72 | 3.50 | 5.58 | 5.66 | 8.21 | 7.10 | 8.83 | 3.58 |
| Tax % | 25.12% | 25.06% | 24.00% | 26.34% | 26.53% | 25.21% | 25.43% | 25.63% | 25.09% | 24.73% | 23.66% | 27.63% | 25.14% |
| Net Profit | 1.55 | 3.05 | 1.71 | 3.30 | 2.77 | 3.52 | 2.61 | 4.15 | 4.24 | 6.17 | 5.42 | 6.39 | 2.68 |
| EPS in Rs | 3.15 | 6.19 | 3.47 | 6.70 | 5.62 | 7.14 | 5.30 | 8.42 | 8.61 | 12.52 | 11.00 | 12.97 | 5.44 |
Last Updated: August 19, 2025, 3:35 pm
Below is a detailed analysis of the quarterly data for Fluidomat Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 12.39 Cr.. The value appears to be declining and may need further review. It has decreased from 20.95 Cr. (Mar 2025) to 12.39 Cr., marking a decrease of 8.56 Cr..
- For Expenses, as of Jun 2025, the value is 9.31 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 12.55 Cr. (Mar 2025) to 9.31 Cr., marking a decrease of 3.24 Cr..
- For Operating Profit, as of Jun 2025, the value is 3.08 Cr.. The value appears to be declining and may need further review. It has decreased from 8.40 Cr. (Mar 2025) to 3.08 Cr., marking a decrease of 5.32 Cr..
- For OPM %, as of Jun 2025, the value is 24.86%. The value appears to be declining and may need further review. It has decreased from 40.10% (Mar 2025) to 24.86%, marking a decrease of 15.24%.
- For Other Income, as of Jun 2025, the value is 0.79 Cr.. The value appears strong and on an upward trend. It has increased from 0.70 Cr. (Mar 2025) to 0.79 Cr., marking an increase of 0.09 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.29 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.27 Cr. (Mar 2025) to 0.29 Cr., marking an increase of 0.02 Cr..
- For Profit before tax, as of Jun 2025, the value is 3.58 Cr.. The value appears to be declining and may need further review. It has decreased from 8.83 Cr. (Mar 2025) to 3.58 Cr., marking a decrease of 5.25 Cr..
- For Tax %, as of Jun 2025, the value is 25.14%. The value appears to be improving (decreasing) as expected. It has decreased from 27.63% (Mar 2025) to 25.14%, marking a decrease of 2.49%.
- For Net Profit, as of Jun 2025, the value is 2.68 Cr.. The value appears to be declining and may need further review. It has decreased from 6.39 Cr. (Mar 2025) to 2.68 Cr., marking a decrease of 3.71 Cr..
- For EPS in Rs, as of Jun 2025, the value is 5.44. The value appears to be declining and may need further review. It has decreased from 12.97 (Mar 2025) to 5.44, marking a decrease of 7.53.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:21 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 28 | 28 | 27 | 26 | 24 | 27 | 25 | 28 | 33 | 45 | 55 | 71 | 69 |
| Expenses | 20 | 20 | 21 | 22 | 21 | 24 | 22 | 23 | 26 | 33 | 40 | 43 | 44 |
| Operating Profit | 8 | 8 | 6 | 4 | 3 | 3 | 3 | 5 | 6 | 12 | 15 | 27 | 25 |
| OPM % | 30% | 28% | 21% | 15% | 12% | 11% | 13% | 17% | 19% | 27% | 27% | 39% | 36% |
| Other Income | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 3 | 3 | 4 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 8 | 8 | 6 | 4 | 3 | 3 | 4 | 5 | 7 | 13 | 18 | 30 | 28 |
| Tax % | 33% | 33% | 33% | 34% | 26% | 28% | 25% | 26% | 26% | 25% | 26% | 25% | |
| Net Profit | 6 | 5 | 4 | 3 | 2 | 2 | 3 | 4 | 5 | 10 | 13 | 22 | 21 |
| EPS in Rs | 11.57 | 10.82 | 8.06 | 5.58 | 4.73 | 4.85 | 6.49 | 8.08 | 11.14 | 19.53 | 26.49 | 45.10 | 41.93 |
| Dividend Payout % | 24% | 25% | 31% | 31% | 37% | 41% | 35% | 40% | 31% | 23% | 17% | 17% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -16.67% | -20.00% | -25.00% | -33.33% | 0.00% | 50.00% | 33.33% | 25.00% | 100.00% | 30.00% | 69.23% |
| Change in YoY Net Profit Growth (%) | 0.00% | -3.33% | -5.00% | -8.33% | 33.33% | 50.00% | -16.67% | -8.33% | 75.00% | -70.00% | 39.23% |
Fluidomat Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 23% |
| 3 Years: | 29% |
| TTM: | 18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 47% |
| 3 Years: | 62% |
| TTM: | 42% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 59% |
| 3 Years: | 80% |
| 1 Year: | 35% |
| Return on Equity | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 22% |
| 3 Years: | 26% |
| Last Year: | 31% |
Last Updated: September 5, 2025, 3:30 pm
Balance Sheet
Last Updated: July 25, 2025, 1:17 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | 16 | 20 | 22 | 25 | 26 | 27 | 28 | 32 | 36 | 44 | 56 | 76 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 7 | 7 | 7 | 6 | 7 | 7 | 7 | 8 | 10 | 11 | 10 | 13 |
| Total Liabilities | 28 | 32 | 34 | 36 | 38 | 40 | 41 | 45 | 51 | 60 | 71 | 93 |
| Fixed Assets | 7 | 8 | 8 | 8 | 7 | 7 | 7 | 7 | 8 | 7 | 8 | 12 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| Investments | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 8 |
| Other Assets | 21 | 24 | 26 | 28 | 29 | 32 | 33 | 37 | 41 | 50 | 58 | 71 |
| Total Assets | 28 | 32 | 34 | 36 | 38 | 40 | 41 | 45 | 51 | 60 | 71 | 93 |
Below is a detailed analysis of the balance sheet data for Fluidomat Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 5.00 Cr..
- For Reserves, as of Mar 2025, the value is 76.00 Cr.. The value appears strong and on an upward trend. It has increased from 56.00 Cr. (Mar 2024) to 76.00 Cr., marking an increase of 20.00 Cr..
- For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 13.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 10.00 Cr. (Mar 2024) to 13.00 Cr., marking an increase of 3.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 93.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 71.00 Cr. (Mar 2024) to 93.00 Cr., marking an increase of 22.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 12.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2024) to 12.00 Cr., marking an increase of 4.00 Cr..
- For CWIP, as of Mar 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 2.00 Cr., marking an increase of 2.00 Cr..
- For Investments, as of Mar 2025, the value is 8.00 Cr.. The value appears strong and on an upward trend. It has increased from 5.00 Cr. (Mar 2024) to 8.00 Cr., marking an increase of 3.00 Cr..
- For Other Assets, as of Mar 2025, the value is 71.00 Cr.. The value appears strong and on an upward trend. It has increased from 58.00 Cr. (Mar 2024) to 71.00 Cr., marking an increase of 13.00 Cr..
- For Total Assets, as of Mar 2025, the value is 93.00 Cr.. The value appears strong and on an upward trend. It has increased from 71.00 Cr. (Mar 2024) to 93.00 Cr., marking an increase of 22.00 Cr..
Notably, the Reserves (76.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 8.00 | 8.00 | 6.00 | 4.00 | 3.00 | 3.00 | 2.00 | 5.00 | 6.00 | 12.00 | 15.00 | 27.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 88 | 103 | 164 | 122 | 160 | 139 | 118 | 117 | 120 | 110 | 90 | 116 |
| Inventory Days | 155 | 212 | 223 | 165 | 181 | 142 | 214 | 189 | 141 | 141 | 113 | 84 |
| Days Payable | 72 | 89 | 75 | 58 | 92 | 79 | 118 | 123 | 137 | 91 | 70 | 53 |
| Cash Conversion Cycle | 170 | 225 | 312 | 228 | 249 | 202 | 214 | 183 | 124 | 159 | 132 | 147 |
| Working Capital Days | 64 | 94 | 164 | 133 | 185 | 169 | 171 | 159 | 146 | 90 | 150 | 155 |
| ROCE % | 45% | 35% | 23% | 15% | 10% | 11% | 13% | 15% | 18% | 29% | 32% | 42% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 19.48 | 11.65 | 8.93 | 6.05 |
| Diluted EPS (Rs.) | 19.48 | 11.65 | 8.93 | 6.05 |
| Cash EPS (Rs.) | 21.01 | 12.47 | 9.39 | 7.82 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 99.84 | 83.86 | 75.45 | 66.52 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 99.84 | 83.86 | 75.45 | 66.52 |
| Revenue From Operations / Share (Rs.) | 93.68 | 69.15 | 57.38 | 51.74 |
| PBDIT / Share (Rs.) | 27.62 | 15.73 | 12.30 | 10.01 |
| PBIT / Share (Rs.) | 26.12 | 14.38 | 11.00 | 8.66 |
| PBT / Share (Rs.) | 26.12 | 15.05 | 10.95 | 8.65 |
| Net Profit / Share (Rs.) | 19.51 | 11.12 | 8.09 | 6.47 |
| NP After MI And SOA / Share (Rs.) | 19.51 | 11.12 | 8.09 | 6.47 |
| PBDIT Margin (%) | 29.48 | 22.75 | 21.43 | 19.33 |
| PBIT Margin (%) | 27.88 | 20.79 | 19.16 | 16.74 |
| PBT Margin (%) | 27.88 | 21.76 | 19.08 | 16.72 |
| Net Profit Margin (%) | 20.82 | 16.07 | 14.09 | 12.51 |
| NP After MI And SOA Margin (%) | 20.82 | 16.07 | 14.09 | 12.51 |
| Return on Networth / Equity (%) | 19.53 | 13.25 | 10.72 | 9.73 |
| Return on Capital Employeed (%) | 25.54 | 16.69 | 14.21 | 12.66 |
| Return On Assets (%) | 16.03 | 10.69 | 8.87 | 7.77 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.02 |
| Asset Turnover Ratio (%) | 0.83 | 0.70 | 0.65 | 0.00 |
| Current Ratio (X) | 2.74 | 2.86 | 3.06 | 2.79 |
| Quick Ratio (X) | 2.07 | 2.32 | 2.25 | 2.05 |
| Inventory Turnover Ratio (X) | 3.10 | 2.36 | 1.90 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 17.94 | 29.23 | 0.00 | 30.88 |
| Dividend Payout Ratio (CP) (%) | 16.66 | 26.05 | 0.00 | 25.59 |
| Earning Retention Ratio (%) | 82.06 | 70.77 | 0.00 | 69.12 |
| Cash Earning Retention Ratio (%) | 83.34 | 73.95 | 0.00 | 74.41 |
| Interest Coverage Ratio (X) | 136101.00 | 2500.90 | 268.10 | 704.26 |
| Interest Coverage Ratio (Post Tax) (X) | 96208.00 | 1660.16 | 177.38 | 456.79 |
| Enterprise Value (Cr.) | 101.07 | 84.85 | 41.93 | 31.44 |
| EV / Net Operating Revenue (X) | 2.19 | 2.49 | 1.48 | 1.23 |
| EV / EBITDA (X) | 7.43 | 10.94 | 6.92 | 6.38 |
| MarketCap / Net Operating Revenue (X) | 2.24 | 2.55 | 1.52 | 1.23 |
| Retention Ratios (%) | 82.05 | 70.76 | 0.00 | 69.11 |
| Price / BV (X) | 2.10 | 2.10 | 1.15 | 0.95 |
| Price / Net Operating Revenue (X) | 2.24 | 2.55 | 1.52 | 1.23 |
| EarningsYield | 0.09 | 0.06 | 0.09 | 0.10 |
After reviewing the key financial ratios for Fluidomat Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 23, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 22) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 23, the value is 19.48. This value is within the healthy range. It has increased from 11.65 (Mar 22) to 19.48, marking an increase of 7.83.
- For Diluted EPS (Rs.), as of Mar 23, the value is 19.48. This value is within the healthy range. It has increased from 11.65 (Mar 22) to 19.48, marking an increase of 7.83.
- For Cash EPS (Rs.), as of Mar 23, the value is 21.01. This value is within the healthy range. It has increased from 12.47 (Mar 22) to 21.01, marking an increase of 8.54.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 23, the value is 99.84. It has increased from 83.86 (Mar 22) to 99.84, marking an increase of 15.98.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 23, the value is 99.84. It has increased from 83.86 (Mar 22) to 99.84, marking an increase of 15.98.
- For Revenue From Operations / Share (Rs.), as of Mar 23, the value is 93.68. It has increased from 69.15 (Mar 22) to 93.68, marking an increase of 24.53.
- For PBDIT / Share (Rs.), as of Mar 23, the value is 27.62. This value is within the healthy range. It has increased from 15.73 (Mar 22) to 27.62, marking an increase of 11.89.
- For PBIT / Share (Rs.), as of Mar 23, the value is 26.12. This value is within the healthy range. It has increased from 14.38 (Mar 22) to 26.12, marking an increase of 11.74.
- For PBT / Share (Rs.), as of Mar 23, the value is 26.12. This value is within the healthy range. It has increased from 15.05 (Mar 22) to 26.12, marking an increase of 11.07.
- For Net Profit / Share (Rs.), as of Mar 23, the value is 19.51. This value is within the healthy range. It has increased from 11.12 (Mar 22) to 19.51, marking an increase of 8.39.
- For NP After MI And SOA / Share (Rs.), as of Mar 23, the value is 19.51. This value is within the healthy range. It has increased from 11.12 (Mar 22) to 19.51, marking an increase of 8.39.
- For PBDIT Margin (%), as of Mar 23, the value is 29.48. This value is within the healthy range. It has increased from 22.75 (Mar 22) to 29.48, marking an increase of 6.73.
- For PBIT Margin (%), as of Mar 23, the value is 27.88. This value exceeds the healthy maximum of 20. It has increased from 20.79 (Mar 22) to 27.88, marking an increase of 7.09.
- For PBT Margin (%), as of Mar 23, the value is 27.88. This value is within the healthy range. It has increased from 21.76 (Mar 22) to 27.88, marking an increase of 6.12.
- For Net Profit Margin (%), as of Mar 23, the value is 20.82. This value exceeds the healthy maximum of 10. It has increased from 16.07 (Mar 22) to 20.82, marking an increase of 4.75.
- For NP After MI And SOA Margin (%), as of Mar 23, the value is 20.82. This value exceeds the healthy maximum of 20. It has increased from 16.07 (Mar 22) to 20.82, marking an increase of 4.75.
- For Return on Networth / Equity (%), as of Mar 23, the value is 19.53. This value is within the healthy range. It has increased from 13.25 (Mar 22) to 19.53, marking an increase of 6.28.
- For Return on Capital Employeed (%), as of Mar 23, the value is 25.54. This value is within the healthy range. It has increased from 16.69 (Mar 22) to 25.54, marking an increase of 8.85.
- For Return On Assets (%), as of Mar 23, the value is 16.03. This value is within the healthy range. It has increased from 10.69 (Mar 22) to 16.03, marking an increase of 5.34.
- For Total Debt / Equity (X), as of Mar 23, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 22) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 23, the value is 0.83. It has increased from 0.70 (Mar 22) to 0.83, marking an increase of 0.13.
- For Current Ratio (X), as of Mar 23, the value is 2.74. This value is within the healthy range. It has decreased from 2.86 (Mar 22) to 2.74, marking a decrease of 0.12.
- For Quick Ratio (X), as of Mar 23, the value is 2.07. This value exceeds the healthy maximum of 2. It has decreased from 2.32 (Mar 22) to 2.07, marking a decrease of 0.25.
- For Inventory Turnover Ratio (X), as of Mar 23, the value is 3.10. This value is below the healthy minimum of 4. It has increased from 2.36 (Mar 22) to 3.10, marking an increase of 0.74.
- For Dividend Payout Ratio (NP) (%), as of Mar 23, the value is 17.94. This value is below the healthy minimum of 20. It has decreased from 29.23 (Mar 22) to 17.94, marking a decrease of 11.29.
- For Dividend Payout Ratio (CP) (%), as of Mar 23, the value is 16.66. This value is below the healthy minimum of 20. It has decreased from 26.05 (Mar 22) to 16.66, marking a decrease of 9.39.
- For Earning Retention Ratio (%), as of Mar 23, the value is 82.06. This value exceeds the healthy maximum of 70. It has increased from 70.77 (Mar 22) to 82.06, marking an increase of 11.29.
- For Cash Earning Retention Ratio (%), as of Mar 23, the value is 83.34. This value exceeds the healthy maximum of 70. It has increased from 73.95 (Mar 22) to 83.34, marking an increase of 9.39.
- For Interest Coverage Ratio (X), as of Mar 23, the value is 136,101.00. This value is within the healthy range. It has increased from 2,500.90 (Mar 22) to 136,101.00, marking an increase of 133,600.10.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 23, the value is 96,208.00. This value is within the healthy range. It has increased from 1,660.16 (Mar 22) to 96,208.00, marking an increase of 94,547.84.
- For Enterprise Value (Cr.), as of Mar 23, the value is 101.07. It has increased from 84.85 (Mar 22) to 101.07, marking an increase of 16.22.
- For EV / Net Operating Revenue (X), as of Mar 23, the value is 2.19. This value is within the healthy range. It has decreased from 2.49 (Mar 22) to 2.19, marking a decrease of 0.30.
- For EV / EBITDA (X), as of Mar 23, the value is 7.43. This value is within the healthy range. It has decreased from 10.94 (Mar 22) to 7.43, marking a decrease of 3.51.
- For MarketCap / Net Operating Revenue (X), as of Mar 23, the value is 2.24. This value is within the healthy range. It has decreased from 2.55 (Mar 22) to 2.24, marking a decrease of 0.31.
- For Retention Ratios (%), as of Mar 23, the value is 82.05. This value exceeds the healthy maximum of 70. It has increased from 70.76 (Mar 22) to 82.05, marking an increase of 11.29.
- For Price / BV (X), as of Mar 23, the value is 2.10. This value is within the healthy range. There is no change compared to the previous period (Mar 22) which recorded 2.10.
- For Price / Net Operating Revenue (X), as of Mar 23, the value is 2.24. This value is within the healthy range. It has decreased from 2.55 (Mar 22) to 2.24, marking a decrease of 0.31.
- For EarningsYield, as of Mar 23, the value is 0.09. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 22) to 0.09, marking an increase of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Fluidomat Ltd:
- Net Profit Margin: 20.82%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 25.54% (Industry Average ROCE: 37.44%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 19.53% (Industry Average ROE: 16.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 96208
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.07
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 22 (Industry average Stock P/E: 49.13)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 20.82%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Engineering - General | 117, 1st Floor, Navneet Darshan, Indore Madhya Pradesh 452018 | info@fluidomat.com http://www.fluidomat.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ashok Jain | Chairman & Managing Director |
| Mrs. Radhica Sharma | Deputy Managing Director |
| Mr. Kunal Jain | Executive Director |
| Mr. Ashok Kumar Patni | Independent Director |
| Mr. Sharad Panot | Independent Director |
| Mr. Samyak Modi | Independent Director |
FAQ
What is the intrinsic value of Fluidomat Ltd?
Fluidomat Ltd's intrinsic value (as of 26 October 2025) is 908.10 which is 1.72% lower the current market price of 924.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 455 Cr. market cap, FY2025-2026 high/low of 1,419/559, reserves of ₹76 Cr, and liabilities of 93 Cr.
What is the Market Cap of Fluidomat Ltd?
The Market Cap of Fluidomat Ltd is 455 Cr..
What is the current Stock Price of Fluidomat Ltd as on 26 October 2025?
The current stock price of Fluidomat Ltd as on 26 October 2025 is 924.
What is the High / Low of Fluidomat Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Fluidomat Ltd stocks is 1,419/559.
What is the Stock P/E of Fluidomat Ltd?
The Stock P/E of Fluidomat Ltd is 22.0.
What is the Book Value of Fluidomat Ltd?
The Book Value of Fluidomat Ltd is 163.
What is the Dividend Yield of Fluidomat Ltd?
The Dividend Yield of Fluidomat Ltd is 0.81 %.
What is the ROCE of Fluidomat Ltd?
The ROCE of Fluidomat Ltd is 42.2 %.
What is the ROE of Fluidomat Ltd?
The ROE of Fluidomat Ltd is 31.4 %.
What is the Face Value of Fluidomat Ltd?
The Face Value of Fluidomat Ltd is 10.0.